Apart from MYC, CTNNB1 (β-catenin) is a frequently mutated oncogene in human HCC (Rebouissou et al., 2016), although the co-occurrence between CTNNB1 and KMT2C mutations was not statistically significant (Figure 1A). The gene discussed is MYC; the disease is hepatocellular carcinoma.